TreeFrog Therapeutics is a French-based biotech aiming to unlock access to #iPS #StemCell derived #CellTherapies for millions of patients. #CellTherapyForAll" title="" class="btn" data-container="body" data-html="true" data-id="61000" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="TreeFrog Therapeutics"> 913 21,599
Global tags
Activities
Technologies
Entity types
Location
30 Av. Gustave Eiffel Bat A, 33600 Pessac, France
Pessac
France
Employees
Scale: 51-200
Estimated: 179
SIREN
343619102Engaged catalyst
51Added in Motherbase
5 years, 7 months agoCell Therapy for All
TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.
TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.
Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.
Cell Therapy, Stem Cell, Stem cell mass-production, Cell therapy cGMP manufacturing, biomimetic 3D cell culture, and bioreactor stem cell cultivation
Cell Therapy for All
TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.
TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.
Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.
TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable to cure millions of patients.
Catalyst | Type | Tweets | Articles | |
---|---|---|---|---|
![]() | Gouvernement | Other 22 May 2024 | | |
![]() Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Other 8 Mar 2023 | | |
![]() Inria Research, Research Services | Inria Research, Research Services | Other 8 Mar 2023 | | |
![]() EY Pythagoras IT Services and IT Consulting | EY Pythagoras IT Services and IT Consulting | Other 25 Nov 2021 | | |
![]() French Tech Bordeaux French Tech, IT Services and IT Consulting | French Tech Bordeaux French Tech, IT Services and IT Consulting | Not capitalistic Not partnership Event 7 Dec 2021 17 Jul 2024 | | |
![]() Moderna Pharmaceutical, Biotechnology, Biotechnology Research | Moderna Pharmaceutical, Biotechnology, Biotechnology Research | Not capitalistic Partnership Event 15 Nov 2021 | | |
![]() BFM Business Media, Broadcast Media Production and Distribution | BFM Business Media, Broadcast Media Production and Distribution | Not capitalistic Not partnership Event 13 Sep 2021 26 Apr 2024 | | |
![]() EU-Startups Media, Software Development | EU-Startups Media, Software Development | Capitalistic Not partnership Not event 13 Sep 2021 | | |
![]() AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 18 Jan 2022 | | |
![]() Pierre Fabre Laboratories Pharmaceutical, Pharmaceutical Manufacturing | Pierre Fabre Laboratories Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Partnership Not event 9 Mar 2020 | |